Administration of glucose-insulin-potassium solution (GIK) and valve replacement in patients with advanced valvular disease.
D000293:Adolescent; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006350:Heart Valve Prosthesis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D011188:Potassium / Q000627:therapeutic use*
D007328:Insulin; D005947:Glucose; D011188:Potassium